Venus Remedies has achieved yet another landmark by securing marketing authorisation from Spain for meropenem, its highest selllng generic product. The company, which has got this approval through its German subsidiary Venus Pharma GmbH for 500mg, 1g and 2g injections of this last-recourse antibiotic, happens to be the largest exporter of meropenem from India in the last three years.
A broad-spectrum antibiotic of the carbapenem class used in intensive care units of hospitals as a last resort for the treatment of life-threatening infections, product meropenem contributes to 40% of the company's total sales. The market size for this product in Europe is about $70.34 million. Venus Remedies has successfully launched this drug in major European markets under its own brand name and through strategic alliance partners by way of tie-ups.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1506.90 |
Dr. Reddys Lab | 6087.65 |
Cipla | 1543.45 |
Zydus Lifesciences | 1093.00 |
Lupin | 1608.50 |
View more.. |